VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 627 filers reported holding VANECK VECTORS ETF TR in Q2 2020. The put-call ratio across all filers is 0.68 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $28,162 | +7.3% | 830 | 0.0% | 0.01% | 0.0% |
| Q1 2024 | $26,245 | +2.0% | 830 | 0.0% | 0.01% | -12.5% |
| Q4 2023 | $25,738 | +15.2% | 830 | 0.0% | 0.01% | +14.3% |
| Q3 2023 | $22,335 | -10.6% | 830 | 0.0% | 0.01% | -12.5% |
| Q2 2023 | $24,991 | -6.9% | 830 | 0.0% | 0.01% | -11.1% |
| Q1 2023 | $26,851 | +12.9% | 830 | 0.0% | 0.01% | 0.0% |
| Q4 2022 | $23,788 | +18.9% | 830 | 0.0% | 0.01% | +12.5% |
| Q3 2022 | $20,000 | -97.6% | 830 | -97.3% | 0.01% | -97.5% |
| Q2 2022 | $829,000 | +2490.6% | 30,284 | +3548.7% | 0.32% | +3120.0% |
| Q1 2022 | $32,000 | -42.9% | 830 | -52.3% | 0.01% | -41.2% |
| Q4 2021 | $56,000 | +9.8% | 1,739 | 0.0% | 0.02% | -5.6% |
| Q3 2021 | $51,000 | -94.7% | 1,739 | -92.9% | 0.02% | -96.0% |
| Q3 2020 | $964,000 | +538.4% | 24,606 | +497.7% | 0.45% | +459.3% |
| Q2 2020 | $151,000 | – | 4,117 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |